SlideShare a Scribd company logo
1 of 38
Rheumatic fever
1
Content
Disease overall view
Precipitating factors
Diagnosis
Management
2
Disease overall view
Rheumatic fever is a systemic autoimmune
disorder related to prior streptococcal infection
The development of rheumatic fever is preceded by the
upper respiratory tract infection (tonsillitis or pharyngitis)
with Group A β-hemolytic streptococci.
3
Disease overall view
Autoimmune mediated by: Antigenic similarity: Abs
formed against streptococcal Ags react with native
human tissue antigens(autoimmune tissue
damage)
The latent period between streptococcal infection
& onset of RF is 1-5 wks.
4
Precipitating factors
Age: between 5-15 yrs.
Sex: equal except for rheumatic chorea (common
in females).
Socio-economic factors: common in developing
countries &low social classes (overcrowding &bad
hygiene).
 Recurrent and severe recent strept. infections
5
Diagnosis
Jone’s criteria
Polyarthritis: w/ low grade fever, large joints,
migratory - often 1 at a time, No permanent
dysfunction. (>75%)
Carditis, pericarditis, cardiomegaly, or
valvulitis (the most serious manifestation &
often results in permanent damage).
(~50%)
plus
Evidence of a recent group A Strep infection
6
Diagnosis
Jone’s criteria
Chorea: late occurrence, 1- 6 months after
the infection, self-limiting, resolves in 1- 3
months. (~30%)
plus
Evidence of a recent group A Strep infection
7
Diagnosis
Jone’s criteria
Erythema Marginatum:
“classic” truncal rash, migratory - appears &
disappears within hours.
 (pink rash – irregular red edges serpiginous
borders– clear center) (~10%)
plus
Evidence of a recent group A Strep infection
8
Diagnosis
Jone’s criteria
Subcutaneous Nodules:
Late occurrence ( months after infection)
 Painless small nodules over bony
prominences:
Elbows
Knees
spine. (1- 2%)plus
Evidence of a recent group A Strep infection
9
Diagnosis
Jone’s criteria
Fever
Arthralgia (mild pain without objective
findings): Can only be considered without
finding of arthritis
Elevated acute-phase reactants: ESR, C-
reactive protein.
plus
Evidence of a recent group A Strep infection
10
Diagnosis
Anti streptococcal Abs are investigated:
ASO
Anti-deoxy-ribonuclease (DNAse) B
Anti-hyaluronidase
Heart reactive antibodies
Tropomyosin is elevated in acute rheumatic
fever.
plus
Evidence of a recent group A Strep infection
11
Diagnosis
Diagnosis with rheumatic fever if you meet two
major criteria, or one major and two minor criteria,
and have signs that you've had a previous strep
infection.
12
Work ups
Complications
Early complications:
( Heart failure, Arrhythmias)
Late complications:
(Rheumatic valvular lesions, rheumatic activity)
13
Management
Acute statePrevent further attacks
2ry1ry
14
Management
Prevention
1ry prevention by treating Strep. Pharyngitis:
The penicillin is the drug of choice because:
Narrow spectrum of activity
Long standing efficacy
Low cost
15
Management
Prevention
IM benzathine penicillin:
1. 0.6 Millions Unit IM 1 Time (< 27 Kg)
2. 1.2 Millions units IM 1 Time (>27 Kg)
16
Management
Prevention
PO - Phenoxymethyl Penicillin (Penicillin V)
1. Children (50mg/kg/day) 250 mg (2-3
times/day) x10 days
2. Adolescent /Adult 500 mg TID x10 days
17
Management
Adverse effect of penicillins
Allergic reaction:
Anaphylaxis, Urticaria
Angioedema, rash.
GIT:
Diarrhea, vomiting & oral thrush
18
Management
Adverse effect of penicillins
Renal:
Acute interstitial nephritis
CNS:
Convulsion & fever
19
Management
Adverse effect of penicillins
Site of injection:
Pain with IM route, inflammation at IV-site
Blood:
Hemolytic anemia, thrombocytopenia,
neutropenia
20
Management
In case of penicillin allergy use:
Oral erythromycin:
(20-40 mg/kg/day)(2-4 times/day)(up to
1gm/day) for 10 days.
Newer macrolides
Oral cephalosporins
21
Management22
Management
Antibiotics “NOT” Recommended for Strep.
Pharyngitis:
Sulfonamides, Trimethoprim, Sulfamethoxazole (not
eradicate GAS).
Tetracyclines / Doxycycline / Minocycline.
(High prevalence of resistant strain)
23
Management
2ry prevention starts after diagnosis of RF:
Rheumatic Fever requires “continuous” prophylactic
antibiotics due to:
1. Increased “susceptibility” to recurrences
2. Increased “severity” of recurrences
3. “Asymptomatic nature” of Strep. Infections.
24
Management25
Or Whichever is longer
Management26
Treatment of:
Arthritis
Carditis
Chorea
Management27
Treatment of:
Arthritis
Relieves by aspirin within 24-48 hrs of pain
The diagnosis is questionable if aspirin isn’t
effective
Mild arthritis may respond to paracetamol
alone
Management28
Treatment of:
Arthritis
Aspirin dose for pediatrics:
90-130 mg/kg/day in equally divided doses
every 4-6 hrs, up to 5.5 gm/day.
Management29
Treatment of:
Arthritis
Salicylate serum levels (20-25 mg/mL)
After 1-2 wks, the dosage is decreased to 60-
70 mg/kg/day and given for 1-6 wks or longer
if necessary, then gradually withdrawn over 1-2
wks.
Management30
Treatment of:
Arthritis
Naproxen/ Ibuprofen/ paracetamol are
potential alternative
Management31
Treatment of:
Carditis
Avoid strenuous exercise
Treat symptoms of heart failure
Steroids are preferred over salicylates
Treatment is guided according to clinical
status of the patient
Management32
Treatment of:
Carditis === severe
case < use prednisolone
2 mg/kg /day 2-4 divided doses (max 60mgm /day )
2-3 wks [ ESR < 30mm / 1hr ]
Taper off 5 mg / 3 days
Add - Aspirin 75 mgm / kg / day x 8 -10 weeks
Management33
Clinical Severity
 Arthralgia or mild
arthritis; no carditis
 Mod./severe arthritis;
no carditis OR carditis
without failure
Treatment
 Analgesics only
 Aspirin 100 mg/kg/d
with meals for 3 wk
(or longer up to 6 wk);
then taper gradually
over 6 wk
Management34
Clinical Severity
 Carditis with failure;
with or without joint
manifestation
Treatment
 Prednisone 40-60
mg/d,  if necessary;
after 3 wk, slow
tapering over 3 wk,
continue aspirin for 4
wk after d/c of
prednisone.
Management35
Treatment of:
Rheumatic chorea
Haloperidol : initial dose 0.5 to 1 mg and 0.5
is added every 3 days for Maximal effect or
until a maximal dose of 5 mg/ day
Sodium valproate: (15 to 20 mg/kg per day)
is also effective.
Management36
Treatment of:
Rheumatic chorea
Diazipam 0.25-0.5 mg/Kg/day
Management37
Treatment of:
Rheumatic chorea
In resistant cases, plasmaphersis iv
Immunoglubulins.
Steroid therapy is generally not effective in
Sydenham’s chorea.
thanks
38

More Related Content

What's hot

What's hot (19)

Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic fever
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Rheumatic fever in pediatrics
Rheumatic fever in pediatricsRheumatic fever in pediatrics
Rheumatic fever in pediatrics
 
Rheumatic Fever
Rheumatic FeverRheumatic Fever
Rheumatic Fever
 
Acute Rheumatic Fever
Acute Rheumatic FeverAcute Rheumatic Fever
Acute Rheumatic Fever
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
4. acute rheumatic fever laboratory manifestations
4. acute rheumatic fever laboratory manifestations4. acute rheumatic fever laboratory manifestations
4. acute rheumatic fever laboratory manifestations
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Rheumatic fever
Rheumatic  feverRheumatic  fever
Rheumatic fever
 
Rheumatic fever in children
Rheumatic fever in childrenRheumatic fever in children
Rheumatic fever in children
 
10 Rheumatic Fever
10 Rheumatic Fever10 Rheumatic Fever
10 Rheumatic Fever
 
Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic fever
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Acute Rheumatic Fever
Acute Rheumatic FeverAcute Rheumatic Fever
Acute Rheumatic Fever
 
Acute Rheumatic Fever
Acute Rheumatic FeverAcute Rheumatic Fever
Acute Rheumatic Fever
 
Acute rheumatic fever ppt final copy
Acute rheumatic fever ppt final copyAcute rheumatic fever ppt final copy
Acute rheumatic fever ppt final copy
 
Rheumatic heart disease
Rheumatic heart diseaseRheumatic heart disease
Rheumatic heart disease
 

Viewers also liked

Cardiology morning presentation 2 im1962012
Cardiology morning presentation 2 im1962012Cardiology morning presentation 2 im1962012
Cardiology morning presentation 2 im1962012hospital
 
heart failure updated
heart failure updatedheart failure updated
heart failure updatedMohammed Adel
 
Anise as estrogenic agent
Anise as estrogenic agentAnise as estrogenic agent
Anise as estrogenic agentTaher Haddad
 
Ventilator Management in Complex Congenital Heart Disease - a case-based review
Ventilator Management in Complex Congenital Heart Disease - a case-based reviewVentilator Management in Complex Congenital Heart Disease - a case-based review
Ventilator Management in Complex Congenital Heart Disease - a case-based reviewGeoffrey Bird
 
Cardiology 1.4. Palpitations - by Dr. Farjad Ikram
Cardiology 1.4. Palpitations - by Dr. Farjad IkramCardiology 1.4. Palpitations - by Dr. Farjad Ikram
Cardiology 1.4. Palpitations - by Dr. Farjad IkramFarjad Ikram
 
IV drug preparation Open heart
IV drug preparation Open heartIV drug preparation Open heart
IV drug preparation Open heartMohammed Adel
 
Ihab Suliman
Ihab SulimanIhab Suliman
Ihab Sulimanhospital
 
Pi specialist, Roles & Responsibilities
Pi specialist, Roles & ResponsibilitiesPi specialist, Roles & Responsibilities
Pi specialist, Roles & ResponsibilitiesDr. Abhimanyu Prashar
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentationTaher Haddad
 
Project Heart Presentation(Students)
Project Heart Presentation(Students)Project Heart Presentation(Students)
Project Heart Presentation(Students)nurjohari
 
Journal-Club-final-1
Journal-Club-final-1Journal-Club-final-1
Journal-Club-final-1Mohammed Adel
 
Cardiology 1.2. Dyspnea - by Dr. Farjad Ikram
Cardiology 1.2. Dyspnea - by Dr. Farjad IkramCardiology 1.2. Dyspnea - by Dr. Farjad Ikram
Cardiology 1.2. Dyspnea - by Dr. Farjad IkramFarjad Ikram
 

Viewers also liked (20)

Amitrityline overdose.pptx1
Amitrityline overdose.pptx1Amitrityline overdose.pptx1
Amitrityline overdose.pptx1
 
cover + presented
cover + presentedcover + presented
cover + presented
 
Antibiotics 1
Antibiotics 1Antibiotics 1
Antibiotics 1
 
1contents
1contents1contents
1contents
 
cardio case (2)
cardio case (2)cardio case (2)
cardio case (2)
 
Cardiology morning presentation 2 im1962012
Cardiology morning presentation 2 im1962012Cardiology morning presentation 2 im1962012
Cardiology morning presentation 2 im1962012
 
pediatrics case VSD
pediatrics case VSDpediatrics case VSD
pediatrics case VSD
 
heart failure updated
heart failure updatedheart failure updated
heart failure updated
 
colts foot
colts footcolts foot
colts foot
 
Anise as estrogenic agent
Anise as estrogenic agentAnise as estrogenic agent
Anise as estrogenic agent
 
Ventilator Management in Complex Congenital Heart Disease - a case-based review
Ventilator Management in Complex Congenital Heart Disease - a case-based reviewVentilator Management in Complex Congenital Heart Disease - a case-based review
Ventilator Management in Complex Congenital Heart Disease - a case-based review
 
Cardiology 1.4. Palpitations - by Dr. Farjad Ikram
Cardiology 1.4. Palpitations - by Dr. Farjad IkramCardiology 1.4. Palpitations - by Dr. Farjad Ikram
Cardiology 1.4. Palpitations - by Dr. Farjad Ikram
 
LVF with HTN and T2DM and PD
LVF with HTN and T2DM and PDLVF with HTN and T2DM and PD
LVF with HTN and T2DM and PD
 
IV drug preparation Open heart
IV drug preparation Open heartIV drug preparation Open heart
IV drug preparation Open heart
 
Ihab Suliman
Ihab SulimanIhab Suliman
Ihab Suliman
 
Pi specialist, Roles & Responsibilities
Pi specialist, Roles & ResponsibilitiesPi specialist, Roles & Responsibilities
Pi specialist, Roles & Responsibilities
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentation
 
Project Heart Presentation(Students)
Project Heart Presentation(Students)Project Heart Presentation(Students)
Project Heart Presentation(Students)
 
Journal-Club-final-1
Journal-Club-final-1Journal-Club-final-1
Journal-Club-final-1
 
Cardiology 1.2. Dyspnea - by Dr. Farjad Ikram
Cardiology 1.2. Dyspnea - by Dr. Farjad IkramCardiology 1.2. Dyspnea - by Dr. Farjad Ikram
Cardiology 1.2. Dyspnea - by Dr. Farjad Ikram
 

Similar to Rheumatic fever causes, symptoms, diagnosis and treatment

Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic feverNizam Uddin
 
Acute rheumatic fever.ppt
Acute rheumatic fever.pptAcute rheumatic fever.ppt
Acute rheumatic fever.pptSani191640
 
Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic fevervijay dihora
 
rheumatic fever in children.pdf
rheumatic fever in children.pdfrheumatic fever in children.pdf
rheumatic fever in children.pdfsazzad92
 
Rheumatic Fever & RHD.pptx
Rheumatic Fever & RHD.pptxRheumatic Fever & RHD.pptx
Rheumatic Fever & RHD.pptxLivson Thomas
 
Pediatric Acute rheumatic fever.ppt
Pediatric Acute rheumatic fever.pptPediatric Acute rheumatic fever.ppt
Pediatric Acute rheumatic fever.pptabdurehmanKassa
 
Acute Rheumatic Fever
Acute Rheumatic FeverAcute Rheumatic Fever
Acute Rheumatic FeverShyala Chand
 
Rheumatic fever 1.pptx
Rheumatic fever 1.pptxRheumatic fever 1.pptx
Rheumatic fever 1.pptxenasfathy3
 
Management of severe asthma an update 2014
Management of severe asthma an update 2014Management of severe asthma an update 2014
Management of severe asthma an update 2014avicena1
 
Rheumatoid arthritis management
Rheumatoid arthritis management Rheumatoid arthritis management
Rheumatoid arthritis management Praveen Nagula
 
4- RHD IE rhumatic heart disease 222.pdf
4- RHD IE rhumatic heart disease 222.pdf4- RHD IE rhumatic heart disease 222.pdf
4- RHD IE rhumatic heart disease 222.pdfPTMAAbdelrahman
 
RheumaticFever.ppt
RheumaticFever.pptRheumaticFever.ppt
RheumaticFever.pptAkmalSharaf1
 
RheumaticFever (1).ppt
RheumaticFever (1).pptRheumaticFever (1).ppt
RheumaticFever (1).pptAaryaJotkar
 
acute rheumatic fever in pediatrics .pptx
acute rheumatic fever in pediatrics .pptxacute rheumatic fever in pediatrics .pptx
acute rheumatic fever in pediatrics .pptxmadhurathore16
 
Biologic Therapy
Biologic TherapyBiologic Therapy
Biologic Therapydrmomusa
 

Similar to Rheumatic fever causes, symptoms, diagnosis and treatment (20)

Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic fever
 
K rheumatic fever-yds
K rheumatic fever-ydsK rheumatic fever-yds
K rheumatic fever-yds
 
Acute rheumatic fever.ppt
Acute rheumatic fever.pptAcute rheumatic fever.ppt
Acute rheumatic fever.ppt
 
Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic fever
 
Rheumatic Fever
Rheumatic FeverRheumatic Fever
Rheumatic Fever
 
rheumatic fever in children.pdf
rheumatic fever in children.pdfrheumatic fever in children.pdf
rheumatic fever in children.pdf
 
11. Rheumatic fever and Rheumatic heart diseases
11. Rheumatic fever and Rheumatic heart diseases11. Rheumatic fever and Rheumatic heart diseases
11. Rheumatic fever and Rheumatic heart diseases
 
Rheumatic Fever & RHD.pptx
Rheumatic Fever & RHD.pptxRheumatic Fever & RHD.pptx
Rheumatic Fever & RHD.pptx
 
Pediatric Acute rheumatic fever.ppt
Pediatric Acute rheumatic fever.pptPediatric Acute rheumatic fever.ppt
Pediatric Acute rheumatic fever.ppt
 
Acute Rheumatic Fever
Acute Rheumatic FeverAcute Rheumatic Fever
Acute Rheumatic Fever
 
Rheumatic fever 1.pptx
Rheumatic fever 1.pptxRheumatic fever 1.pptx
Rheumatic fever 1.pptx
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Management of severe asthma an update 2014
Management of severe asthma an update 2014Management of severe asthma an update 2014
Management of severe asthma an update 2014
 
Rheumatoid arthritis management
Rheumatoid arthritis management Rheumatoid arthritis management
Rheumatoid arthritis management
 
4- RHD IE rhumatic heart disease 222.pdf
4- RHD IE rhumatic heart disease 222.pdf4- RHD IE rhumatic heart disease 222.pdf
4- RHD IE rhumatic heart disease 222.pdf
 
Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic fever
 
RheumaticFever.ppt
RheumaticFever.pptRheumaticFever.ppt
RheumaticFever.ppt
 
RheumaticFever (1).ppt
RheumaticFever (1).pptRheumaticFever (1).ppt
RheumaticFever (1).ppt
 
acute rheumatic fever in pediatrics .pptx
acute rheumatic fever in pediatrics .pptxacute rheumatic fever in pediatrics .pptx
acute rheumatic fever in pediatrics .pptx
 
Biologic Therapy
Biologic TherapyBiologic Therapy
Biologic Therapy
 

More from Mohammed Adel

UFH & LMWH & fondaparinux
UFH & LMWH & fondaparinuxUFH & LMWH & fondaparinux
UFH & LMWH & fondaparinuxMohammed Adel
 
METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)Mohammed Adel
 
Diabetic Keto-Acidosis final
Diabetic Keto-Acidosis finalDiabetic Keto-Acidosis final
Diabetic Keto-Acidosis finalMohammed Adel
 

More from Mohammed Adel (6)

UFH & LMWH & fondaparinux
UFH & LMWH & fondaparinuxUFH & LMWH & fondaparinux
UFH & LMWH & fondaparinux
 
Bitter Melon
Bitter MelonBitter Melon
Bitter Melon
 
angina presentation
angina presentationangina presentation
angina presentation
 
streptogramin final
streptogramin finalstreptogramin final
streptogramin final
 
METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)
 
Diabetic Keto-Acidosis final
Diabetic Keto-Acidosis finalDiabetic Keto-Acidosis final
Diabetic Keto-Acidosis final
 

Rheumatic fever causes, symptoms, diagnosis and treatment

Editor's Notes

  1. Endocarditis prophylaxis ماتنساش تقولها
  2. Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
  3. Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 20-25 mg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
  4. Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
  5. Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
  6. Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
  7. Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
  8. Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
  9. Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
  10. Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
  11. Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.